Income Tax Expense (Benefit) of Protagenic Therapeutics, Inc.\new from 30 Jun 2010 to 30 Sep 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Protagenic Therapeutics, Inc.\new quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 30 Jun 2010 to 30 Sep 2024.
Protagenic Therapeutics, Inc.\new Income Tax Expense (Benefit) for the quarter ending 30 Sep 2024 was $2,524.
Protagenic Therapeutics, Inc.\new annual Income Tax Expense (Benefit) for 2016 was $0.
Protagenic Therapeutics, Inc.\new annual Income Tax Expense (Benefit) for 2015 was $0.
Protagenic Therapeutics, Inc.\new annual Income Tax Expense (Benefit) for 2014 was $0.
Source SEC data: View on sec.gov

Income Tax Expense (Benefit), Quarterly (USD)

Income Tax Expense (Benefit), YoY Quarterly Change (%)

Income Tax Expense (Benefit), Annual (USD)

Protagenic Therapeutics, Inc.\new Quarterly Income Tax Expense (Benefit) (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2024	$2,524			01 Jul 2024	30 Sep 2024	10-Q	26 Nov 2025	2026	Q2
Q2 2024	$2,524			01 Apr 2024	30 Jun 2024	10-QT	10 Sep 2025	2026	Q1
Q3 2011	$45,000	+$10,000	+29%	01 Jul 2011	30 Sep 2011	10-Q	14 Nov 2011	2011	Q3
Q2 2011	$26,000	-$83,000	-76%	01 Apr 2011	30 Jun 2011	10-Q/A	07 Sep 2011	2011	Q2
Q3 2010	$35,000			01 Jul 2010	30 Sep 2010	10-Q	14 Nov 2011	2011	Q3
Q2 2010	$109,000			01 Apr 2010	30 Jun 2010	10-Q/A	07 Sep 2011	2011	Q2

Period	Value	YoY Chg	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2016	$0	$0	01 Jan 2016	31 Dec 2016	10-K/A	08 May 2017	2016	FY
2015	$0	$0	01 Jan 2015	31 Dec 2015	10-K/A	08 May 2017	2016	FY
2014	$0	$0	01 Jul 2013	30 Jun 2014	10-K	25 Sep 2015	2015	FY
2013	$0		01 Jul 2012	30 Jun 2013	10-K	14 Oct 2014	2014	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.